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a  b  s  t  r  a  c  t
Emery-Dreifuss  muscular  dystrophy  (EDMD)  is  a  late  onset-disease  characterized  by  skeletal  muscle
wasting  and  heart  defects  with  associated  risk  of  sudden  death.  The  autosomal  dominant  form  of  the
disease  is  caused  by  mutations  in the  LMNA  gene  encoding  LaminA  and  C, the  X-linked  form  results  from
mutations  in  the  gene  encoding  the  inner  nuclear  membrane  protein  Emerin  (STA).  Both  Emerin  and
LaminA/C  interact  with  the  nuclear  envelope  proteins  Nesprin-1  and  -2  and  mutations  in genes  encoding
C-terminal  isoforms  of  Nesprin-1  and  -2  have  also  been  implicated  in  EDMD.  Here  we  analyse  primary
ﬁbroblasts  from  patients  affected  by  either  Duchenne  muscular  dystrophy  (DMD)  or  Emery-Dreifuss
muscular  dystrophy/Charcot-Marie-Tooth  syndrome  (EDMD/CMT)  that  in addition  to  the disease  causingaminopathy
DMD
uscular dystrophy
UN2 proteome
mutations  harbour  mutations  in  the Nesprin-1  gene  and  in  the  SUN1  and  SUN2  gene,  respectively.  SUN
proteins  together  with  the  Nesprins  form  the  core  of  the  LINC  complex  which  connects  the  nucleus  with
the cytoskeleton.  The  mutations  are  accompanied  by  changes  in  cell  adhesion,  cell  migration,  senescence,
and  stress  response,  as  well  as  in  nuclear  shape  and  nuclear  envelope  composition  which  are  changes
characteristic  for laminopathies.  Our  results  point  to  a  potential  inﬂuence  of mutations  in components
of  the  LINC  complex  on the  clinical  outcome  and  the  molecular  pathology  in  the  patients.ntroduction
The nuclear envelope (NE) forms an interface between the cyto-
lasm and the nuclear interior during interphase. It is composed
f the outer and inner nuclear membranes (ONM and INM, respec-
ively), the nuclear lamina and the nuclear pore complexes (NPCs).
he ONM is continuous with the endoplasmic reticulum (ER) and
onnects with the INM at the NPCs, the INM associates with the
uclear lamina and with chromatin (Mellad et al., 2011; Starr and
ridolfsson, 2010). The NE proteome comprises several proteins
hat perform critical functions in the maintenance of nuclear archi-
ecture, positioning and migration. Mutations in these proteins lead
o a variety of diseases, collectively called laminopathies, includ-
ng partial lipodystrophy, mandibulolacral dysplasia (MAD), dilated
ardiomyopathy, autosomal-dominant limb-girdle muscular dys-
rophy type 1B (LGMD1B), Charcot-Marie-Tooth neuropathy type
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2B1 (CMT2B1), restrictive dermopathy, Hutchinson-Gilford proge-
ria, Werner’s syndrome and Emery-Dreifuss muscular dystrophy
(EDMD) (Capell and Collins, 2006). EDMD is typically characterised
by the clinical triad of (1) early contractures of the Achilles ten-
dons, elbows and postcervical muscles (with subsequent limitation
of neck ﬂexion, but later forward ﬂexion of the entire spine becomes
limited); (2) progressive skeletal muscle weakness and wasting
with a humero-peroneal predominance at the onset of the dis-
ease (i.e. proximal in the upper limbs and distal in the lower limbs)
and (3) a life threatening cardiac disease where conduction defects
coexist with ventricular and supraventricular arrhythmias, cham-
ber dilation and heart failure.
Charcot-Marie-Tooth disease (CMT) constitutes a clinically and
genetically heterogeneous group of hereditary motor and sensory
neuropathies. On the basis of electrophysiological criteria, CMT
can be divided into two major types: type 1, the demyelinating
forms, characterised by a motor median nerve conduction veloc-
ity less than 38 m/s; and type 2, the axonal form, with a normal
or slightly reduced nerve conduction velocity (The UMD-LMNA
Open access under CC BY license.database: www.umd.be/LMNA).
To date, mutations in LMNA,  STA and the Nesprin-1 and
-2 genes SYNE1 and SYNE2 have been associated with EDMD.
Mutations in the LMNA gene encoding the intermediate ﬁlament
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roteins LaminA and C of the nuclear lamina cause the autoso-
al  dominant form of the disease while mutations in the STA gene
ncoding the INM protein Emerin cause the X-linked form (Bione
t al., 1994; Bonne et al., 1999; Manilal et al., 1996; Nagano et al.,
006). SUN proteins like SUN1 and SUN2 and Nesprin-1 and- 2 are
irect interaction partners of Emerin and LaminA/C and are can-
idates for those cases of EDMD which do not involve Emerin or
aminA/C (Zhang et al., 2007).
SUN1 and 2 are widely expressed type II INM proteins contain-
ng at least one transmembrane domain and a conserved C-terminal
UN domain located within the lumen of the NE. Through this
omain they can recruit KASH (Klarsicht, ANC-1, Syne homol-
gy) domain proteins to the NE forming the LINC complex (linker
f nucleoskeleton and cytoskeleton) that provides a connection
etween the nucleoplasm and the cytoplasm and links it to the
ytoskeleton (Crisp et al., 2006; Haque et al., 2006; Padmakumar
t al., 2005; Starr and Han, 2002; Starr et al., 2001; Stewart et al.,
007; Stewart-Hutchinson et al., 2008).
The KASH domain containing Nesprins (Nuclear envelope
pectrin repeat proteins) are spectrin repeat containing type II
ransmembrane proteins that localise to the nuclear envelope
nd are encoded by independent genes. Several isoforms exist
hat are generated by the use of internal initiation sites or by
lternative splicing and vary in domain composition. The largest
soforms of Nesprin-1 and -2 (∼1000 kDa and ∼800 kDa, respec-
ively) contain an N-terminal actin binding domain, a long rod
omain with several spectrin repeats and a C-terminal KASH
omain which tethers them to the nuclear membrane (Apel et al.,
000; Mislow et al., 2002a; Padmakumar et al., 2004; Simpson and
oberts, 2008; Zhen et al., 2002). Here we analysed components
f the LINC complex in ﬁbroblasts from a healthy donor indi-
idual and patients suffering from Duchenne muscular dystrophy
DMD) and Emery-Dreifuss muscular dystrophy/Charcot-Marie-
ooth syndrome (EDMD/CMT). Sequence analysis revealed a
utation in the DMD  gene in the case of the DMD  patient, whereas
or the EDMD/CMT the underlying mutation could not be identi-
ed. Furthermore, the patients harboured additional mutations in
omponents of the LINC complex which initiated an analysis of NE
omponents with particular emphasis on SUN2 and led to the estab-
ishment of a SUN2 proteome for the EDMD/CMT ﬁbroblasts which
ight deliver novel insights into the underlying pathomechanism
f the disease.
aterials and methods
ell culture
Human control and patient primary ﬁbroblasts of a male (G-
1235) and a female patient (G-11847) suffering from Duchenne
uscular dystrophy (DMD) and Emery-Dreifuss and Charcot-
arie-Tooth syndrome (EDMD/CMT), respectively, were cultured
n Eagle’s DMEM (Gibco) supplemented with 20% FBS, 1 mM glu-
amine, 1% penicillin/streptomycin and 7.5% sodium bicarbonate
t 37 ◦C and 5% CO2. Patients and mutation analysis have been
escribed in Zhang et al. (2007).  Cells were used between passage
 and passage 16 as indicated. DMD  myoﬁbroblasts were obtained
rom the Muscle Tissue Culture Collection, Friedrich-Baur-Institute,
MU  München.
ransfection experiments
A mutation at position c.278A>C of SUN1 which leads to an
mino acid exchange p.Q93P was introduced into plasmid GFP-
Sun1 (Lu et al., 2008). Sun2-V5-His (Lu et al., 2008) was  used
or introduction of the mutation at position c.97A>G which leads
o an amino acid exchange p.T33A in SUN2. A site directed Cell Biology 91 (2012) 614– 628 615
mutagenesis kit (Promega) was used. The mutation was conﬁrmed
by DNA sequencing. HaCaT cells were transfected using the Amaxa
cell line Nucleofector® kit V (Lonza) according to the manufac-
turer’s instructions. Cells were analysed by confocal microscopy
for the presence and distribution of nuclear envelope markers.
Immunoﬂuorescence analysis
Cultured cells grown on coverslips were ﬁxed in 3%
paraformaldehyde in PBS for 10 min  followed by permeabili-
sation with 0.5% Triton X-100 for 5 min  for Nesprin-2 staining.
Alternatively, cells were ﬁxed in cold methanol (−20 ◦C) for
5 min  for Nesprin-1 staining. The following antibodies were
used: mouse monoclonal anti-Nesprin-2 mAb K20-478 (Zhen
et al., 2002), afﬁnity-puriﬁed rabbit anti-Nesprin-1 antibody
SpecII (this study), rabbit polyclonal Nesprin-2 pAbK1 (Libotte
et al., 2005), rabbit anti-LaminB1 polyclonal antibodies (Abcam),
mouse monoclonal anti-Emerin (Abcam), rabbit polyclonal
anti-LaminA/C (Santa Cruz), polyclonal antibodies speciﬁc for
pericentrin (Abcam), mouse monoclonal anti vinculin antibody
(Sigma), mouse monoclonal anti-V5 antibody (Invitrogen). The
secondary antibodies used were conjugated with Alexa Fluor 488
(Molecular Probes), Cy3, TRITC and FITC (Sigma). The samples
were counterstained with DAPI (Sigma) and mounted in gelvatol.
Samples were analysed using confocal laser scanning microscopy
(TCS-SP5, Leica). In general, cells between passages 8 and 16 were
used for immunoﬂuorescence.
Antibody generation
For the investigation of Nesprin-1 polyclonal antibodies (SpecII)
directed against the C-terminus of human Nesprin-1 were gen-
erated. The last two  spectrin repeats (residues 8394–8608) of
Nesprin-1 were expressed as GST-fusion protein (GST-SpecII) and
used for immunisation of rabbits. Nesprin-1 speciﬁc antibodies
were puriﬁed by afﬁnity chromatography. For this, the Nesprin-1
polypeptide of GST-SpecII was cleaved from GST with thrombin,
dialysed and coupled to CNBr-activated sepharose. The puriﬁed
antibodies were highly speciﬁc for Nesprin-1. They reacted with
GFP fusion proteins containing the Nesprin-1 C-terminus but
not with GFP-fusions of the corresponding Nesprin-2 C-terminal
sequences. They were used for immunoﬂuorescence and Western
blot analysis. Monoclonal antibodies speciﬁc for SUN2 were gener-
ated against an N-terminal polypeptide of human SUN2 (Q9UH99),
SUN2Nt, encompassing residues 1–138 and which is located in
the nucleoplasm. The ∼15 kDa polypeptide has a pI of 9.4. It was
expressed as GST-fusion in E. coli XL1-Blue. After thrombin cleavage
the polypeptide was used for immunisation of mice. mAb  K80-207
was  used in this work. The speciﬁcity of the antibodies was  con-
ﬁrmed in experiments with V5-His-tagged SUN2 (Lu et al., 2008).
Western blotting
Cells were grown to conﬂuency, washed twice with ice cold PBS
and resuspended in modiﬁed radio-immunoprecipitation (RIPA)
lysis buffer (50 mM Tris–HCl, pH 7.5, 150 mM  NaCl, 1% NP-40, 0.5%
Na desoxycholate, 0.1% SDS, 1 mM dithiothreitol, 1 mM benzami-
dine, 1 mM PMSF, 1 mM  EGTA, 10 g/ml aprotinin and 10 g/ml
leupeptin). Cell suspensions were passed through a 0.45 m needle
10 times and incubated for 15 min  on ice, followed by sonica-
tion. The lysates were cleared by centrifugation at 10,000 rpm
for 5 min  at 4 ◦C. The samples were resuspended in 5× SDS  sam-
ple buffer and heated at 98 ◦C for 5–10 min. For Western blot
analysis, proteins were resolved on 10%, 12% SDS- or 3–15%
gradient SDS polyacrylamide gels and transferred to PVDF mem-
brane (Pall Corporation) over 24–72 h. The blots were probed
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ith primary antibodies, washed with TBST (10 mM Tris–HCl, pH
.0, 150 mM NaCl and 0.05% Tween-20) several times and incu-
ated with horseradish peroxidase-coupled secondary antibody
Dianova, Germany). The blots were washed again with TBST
nd visualised using enhanced chemiluminescence (ECL) system
Luminol, p-Cumaric acid, Sigma–Aldrich, Steinheim, Germany).
or control -tubulin speciﬁc antibody mAb  WA3  provided by
r. U. Euteneuer was used.
eat stress experiments
Normal and patient ﬁbroblasts were trypsinised two days before
he experiment and plated on 12 mm glass coverslips and cultured
t 37 ◦C. For heat stress, cells were placed in an incubator set at
5 ◦C for 30 min  and ﬁxed immediately after treatment with cold
ethanol at −20 ◦C for 5 min  and incubated with anti-LaminB1
abbit polyclonal antibodies or monoclonal antibody 4G5 (Abcam)
gainst emerin to detect the nuclear envelope and pericentrin spe-
iﬁc polyclonal antibodies to detect the centrosome. Untreated
ormal and patient ﬁbroblasts were used as control.
ST pull-down assay
Recombinant GST-SUN2Nt polypeptide expression was induced
n E. coli strain BL21 (0.5 mM IPTG, 4 h, 37 ◦C). Cells were lysed as
escribed (Libotte et al., 2005) and the proteins were isolated from
he supernatant by incubating with glutathione agarose beads (4 h,
◦C). Glutathione agarose beads coupled with GST-SUN2Nt were
ashed ﬁve times with PBS (500 g, 4 ◦C, 1 min) before incubating
ith the according human ﬁbroblast total cell lysates (100,000 g
upernatant) at 4 ◦C for 6 h. Beads were washed three times with
BS (500 g, 4 ◦C, 1 min) and heated in SDS sample buffer (95 ◦C,
 min). Samples were analysed using 12% SDS polyacrylamide gels
nd stained with Coomassie Brilliant Blue. Protein bands of inter-
st were excised from the gels and subjected to LCMS analysis. The
xperiment was carried out twice. For the analysis we used control
broblasts and EDMD/CMT ﬁbroblasts. The EDMD/CMT ﬁbroblasts
ere taken at passage 6 and 8, respectively.
enescence-associated ˇ-galactosidase assays
Cells were seeded on cover slips; the next day cover slips were
ashed with PBS and ﬁxed with 3% PFA (5 min, RT). Cells were
ashed twice with PBS and incubated at 37 ◦C with freshly pre-
ared senescence-associated -Gal (SA--Gal) staining solution
van der Loo et al., 1998). Examination for staining was done after
–8 h under bright ﬁeld microscopy at 40× magniﬁcation.
NA isolation and cDNA generation for quantitative RT-PCR
nalysis
Total RNA was  extracted from cells grown in a monolayer in cell
ulture dishes with a kit following the instructions of the supplier
Promega, Heidelberg, Germany). First-strand cDNA synthesis was
erformed using M-MLV  reverse transcriptase RNase H Minus-kit
rom Promega. To evaluate the gene expression level of SUN2 by
uantitative RT-PCR in the patient ﬁbroblast in comparison to the
ontrol ﬁbroblasts, total RNA was isolated from control ﬁbroblasts
t passage 8 and 22, EDMD/CMT ﬁbroblasts at passage 4 and 16,
MD  ﬁbroblasts at passage 6 and 8. For normalisation GAPDH
xpression was used.ocal adhesion assay
Trypsinised cells were seeded on coverslips in culture
ishes with an initial cell number of 1 × 103 and subjected to Cell Biology 91 (2012) 614– 628
immunoﬂuorescence as described above by staining for vinculin.
Analysis was carried out with a confocal laser scanning microscope
TCS-SP5 (Leica) equipped with TCSNT software. The individual
immunoﬂuorescences shown in Fig. 4A have the same magniﬁca-
tion (scale bar, 76.4 m)  and were taken in the same z-plane so that
the spreading of focal adhesions on the surface of the coverslip is
comparable. LAS-AF Lite Application Suite software from Leica was
used to quantify the spreading area in m2.
Wound healing assay
Control and patient cells were grown on 10 cm tissue culture
plates until nearly conﬂuent. Before experimentation, the cells
were serum-starved overnight. The next day the medium was
replaced with serum-supplemented normal growth medium. A
scratch was  made in the monolayer with a 200 l tip and the rate of
cell migration into the wounded area was monitored using bright
ﬁeld microscopy. Images were captured at various time points and
the distance migrated by the cells was  calculated by measuring the
open wound area. Experiments were repeated at least thrice for
each cell type.
Results
Case report of Duchenne muscular dystrophy (DMD), and
Emery-Dreifuss muscular dystrophy/Charcot-Marie-Tooth
syndrome (EDMD/CMT) patients
We used primary ﬁbroblasts from a patient (G-11235) suffering
from a muscular dystrophy compatible with a clinical phenotype
of Emery-Dreifuss muscular dystrophy (EDMD). Mutational anal-
ysis was  negative in the genes known to be associated to EDMD
including STA, LMNA FHL1. We  therefore extended the analysis
to components of the LINC complex and sequenced in particular
coding exons of Nesprin-11, Nesprin-12, Nesprin-21,  Nesprin-
22, Nesprin-21  and Nesprin-22, SUN1 and SUN2. The DMD  gene
was  sequenced as well. This revealed the presence of a nonsense
mutation c.3409C>T in the DMD  gene leading to a truncated dys-
trophin p.E1137X. The p.E1137X mutation is located in spectrin
repeat 7 of the protein (Legrand et al., 2011) (NCBI AAA53189.1).
Based on this, patient G-11235 should phenotypically be consid-
ered as Duchenne muscular dystrophy (DMD). In addition, patient
G-11235 had a 29A>G mutation in the 5′UTR of the Nesprin-12
isoform which was  not present in a reference population (386 alle-
les) suggesting a transcriptional mis-regulation of this Nesprin-1
isoform. Nesprin-1 is a C-terminal isoform of Nesprin-1 and is
primarily expressed in skeletal and cardiac muscle. It contains a
transmembrane domain and several spectrin repeats but lacks the
actin binding domain (Apel et al., 2000; Mislow et al., 2002a). The
patient further harboured a mutation in SUN1 (c.278A>C, p.Q93P).
Patient G-11847 suffers from a neuromuscular disorder showing
clinical signs of EDMD and Charcot-Marie-Tooth syndrome (CMT).
She was  found to be heterozygous for a mutation p.N323H in a
spectrin repeat of Nesprin-11. The patient inherited this mutation
from her clinically healthy Asian mother. The p.N323H mutation
was  not found in Caucasians (254 alleles) but occurred in 4% of an
Asian reference population (150 alleles). No primarily pathogenic
mutation for the disease in G-11847 could be found. G-11847 also
carried a mutation in SUN2 at position c.97A>G which leads to
an amino acid exchange p.T33A. This exchange represents a rare
variant which appears to occur only in Asian populations (2/252
chromosomes). At the protein level, the mutation is located in the
highly conserved N-terminal region of SUN2.
Obviously, the Nesprin-1 mutations found in patients G-11235
and 11847, respectively, are not primarily pathogenic. However, to
S. Taranum et al. / European Journal of Cell Biology 91 (2012) 614– 628 617
Fig. 1. Nuclear defects in DMD  and EDMD/CMT ﬁbroblasts. (a) Control (ctrl) and patient ﬁbroblasts (EDMD/CMT, DMD) were stained for Emerin (left panel) and LaminA
(middle panel). Merge, right panel. Arrows in ctrl, Emerin and LaminA/C colocalisation; arrowheads (EDMD/CMT), colocalisation of Emerin and LaminA/C in nuclear patches;
DMD,  arrow, nuclear lobulation and bleb; DMD, middle panel, arrow head points to a nuclear patch. Alexa Fluor 568 and 488 conjugated secondary antibodies were used and
DAPI  for nuclear staining. Bar, 10 m.  (b) The statistical analysis shows the increase of micronuclei and misshapen nuclei at increased passages. As misshapen we deﬁned
nuclei  which did not have an ovoid or round shape. One hundred nuclei per control and patient cells were evaluated at passage 8, 12 and 16 each. The error bars indicate
standard deviations. The experiment was carried out twice.
618 S. Taranum et al. / European Journal of Cell Biology 91 (2012) 614– 628
Fig. 2. The distribution of nuclear envelope proteins is altered in patient ﬁbroblasts. (a) LaminB1 was  stained using anti-LaminB1 as ﬁrst antibodies; Alexa Fluor 568 as
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efects  in Emerin and LaminA/C localisation (see Fig. 1a for staining) was carried ou
ndicate  standard deviations.
nd out a possible contribution of those Nesprin-1 mutations to the
linical outcome we carried out investigations on the cellular level
o probe for alterations that are associated with diseases caused by
utations in components of the NE.
atient ﬁbroblasts show nuclear shape defects and have
lterations in components of the nuclear envelope
Nuclei of control cells generally have a round or ovoid shape. In
he patient ﬁbroblasts we noted a variety of nuclear shape defects
ncluding folds, lobulations, blebs and micronuclei (Fig. 1a). Quan-
iﬁcation showed that the number of cells with nuclear defects
as increased compared to control cells (Fig. 1b). The DMD  patient
ells exhibited the most signiﬁcant nuclear shape alterations. At an
verage, 30% of DMD  cells showed misshapen nuclei with a slight
ncrease from passage 8 to passage 16. In contrast, EDMD/CMT
broblasts exhibited 15 and 19% misshapen cells in passage 8 and
assage 12, respectively, and at passage 16 an increase to 32% was
bserved. The relation between micronuclei and misshapen cells
orrelated and remained almost constant (Fig. 1b).
When probing NE components in immunoﬂuorescence analyses
e found that nuclei of control cells displayed homogenous distri-
ution of Emerin and LaminA/C at the nuclear periphery. LaminA/C
howed in addition an even distribution throughout the nucleus
Fig. 1a, arrows). In EDMD/CMT patient ﬁbroblasts, the periph-
ral distribution of Emerin was altered to a patchy staining of
he nucleus which was also observed for LaminA/C (Fig. 1a). In
act, Emerin and LaminA/C colocalise frequently in these patches
Fig. 1a, arrowheads). In the DMD  cells the nuclear rim staining was
etained for Emerin and Lamin and a localisation of Emerin andate the defects described in the text. Bar, 10 m.  (b) Statistical analysis of observed
ach mutation. Nearly 300 nuclei were counted for each sample analysed. Error bars
LaminA/C in blebs and protrusions was observed in dysmorphic
nuclei (Fig. 1a, arrow). Further, a fraction of ﬁbroblasts also dis-
played reduced LaminA/C staining. However, in the nuclear blebs
depleted for LaminA/C, Emerin staining was still observed (Fig. 1a,
arrows).
LaminB1 antibodies showed the protein at the nuclear enve-
lope in control ﬁbroblasts (Fig. 2a). In EDMD/CMT ﬁbroblasts the
staining was discontinuous in nuclei that had blebs and blebs did
not show signiﬁcant LaminB1 labelling (Fig. 2a, arrowhead). Nuclei
with normal shape showed the expected nuclear distribution of
LaminB1 (Fig. 2a, arrow). In DMD  ﬁbroblasts the nuclear rim stain-
ing was not homogenous in misshapen nuclei (Fig. 2a, arrowhead).
This aspect was observed in nuclei from cells at different passage
numbers. Another notable aspect was  the elongated appearance of
nuclei in a fraction of cells. A statistical analysis was carried out to
quantify the observations which conﬁrmed increased numbers of
patient cells exhibiting abnormalities (Figs. 2b and 3b).
When we tested cells from patients suffering from Becker mus-
cular dystrophy for nuclear shape and distribution of NE proteins
we observed normal shaped nuclei and a regular staining for the
NE proteins (data not shown). This suggests that nuclear shape
alterations are not generally associated with muscular dystrophy
mutation. The patients harboured deletions of exons 2–11, exons
3–7 and 52–60, respectively, in the DMD gene.
Nesprin distribution and abundance is altered in control and
patient ﬁbroblasts
Based on the ﬁndings that the patients have mutations in
Nesprin-1 we investigated the localisation of Nesprin-1 and 2 using
S. Taranum et al. / European Journal of
Fig. 3. Nesprin-1 and -2 localisation is altered in ﬁbroblasts from DMD and
EDMD/CMT patients. (a) Control, EDMD/CMT and DMD  ﬁbroblasts were stained for
Nesprin1 using anti-Nesprin-1 SpecII and Nesprin-2 using pAbK1 and mAb  K20-478
speciﬁc for the C- and N-terminus of Nesprin-2, respectively, as ﬁrst antibodies;
Alexa Fluor 568 and 488 as secondary antibodies; DAPI for nuclear staining. Arrows
and  arrowheads indicate the defects described in the text. Bar, 10 m.  (b) Statistical
evaluation of the observed defects. Approximately 300 nuclei were evaluated for
each mutation. (c) Presence of Nesprin-1 isoforms and of Nesprin-2 Giant in control
and patient ﬁbroblasts. Cell lysates were separated on SDS gradient gels (3–15% acry-
lamide) and probed with SpecII antibodies speciﬁc for Nesprin-1 and mAb  K20-478
recognising the ∼800 kDa Nesprin-2 Giant. Equal loading was  assessed by Ponceau
S  staining of the blots. Cell Biology 91 (2012) 614– 628 619
polyclonal antibodies directed against the C-terminus of Nesprin-1
and -2 (SpecII and pAbK1, respectively) and mAb  K20-478 directed
against the N-terminus of Nesprin-2 to detect Nesprin-2 Giant
(Padmakumar et al., 2005; Zhen et al., 2002). Control cells exhib-
ited clear nuclear envelope localisation for both Nesprin-1 and -2
with C-terminus speciﬁc antibodies (Fig. 3a, A, D, arrow). Nuclear
staining was also observed for Nesprin-2 Giant with mAb  K20-478
(Fig. 3a, G). EDMD/CMT and DMD  cells showed nuclear envelope
staining for Nesprin-1 (Fig. 3a, B, C). In irregular shaped nuclei
we saw also distribution into folds and pleats (Fig. 3a, B, arrow-
head). pAbK1 recognised Nesprin-2 at the nuclear envelope, and
nuclei with misshapen morphology showed Nesprin-2 distribution
into blebs (Fig. 3a, E, arrowhead). By contrast, envelope staining
with mAb  K20-478 was not pronounced in both patient ﬁbroblasts.
Instead, Nesprin-2 Giant staining was uniform throughout the
nucleus in normal shaped nuclei and in nuclei with altered shape.
A fraction of nuclei in the DMD  cells showed diminished nuclear
staining of Nesprin-2 Giant with concomitant defects in the nuclear
shape (Fig. 3a, I, asterisk). A statistical evaluation revealed the
increase of micronuclei, mislocalisation of Nesprins and reduced
staining in the patient cells (Fig. 3b).
To analyse the isoform expression patterns of Nesprin-1 and -2,
we performed Western blot analysis with pAb SpecII for Nesprin-1
and mAb  K20-478 speciﬁc for Nesprin-2 (Fig. 3c). For Nesprin-1 we
observed a similar pattern in control and patient cell lysates and
detected proteins of ∼250 kDa, 400 and 600 kDa (Fig. 3c, arrows).
However the intensity of the 250 and 400 kDa protein bands was
reduced. This was most prominent in the DMD  ﬁbroblasts. Fur-
thermore, proteins of lower molecular masses corresponding to
C-terminal Nesprin-1 isoforms were not visible in the patient
lysates. By contrast, Nesprin-2 Giant levels were comparable to the
control in both patient cell lines.
SUN2 gene expression is down-regulated during passaging of
patient cells
SUN proteins are essential components of the LINC complex.
In humans there exist several SUN isoforms with SUN2 being the
ubiquitously expressed one. In the following studies we focused on
SUN2 as the gene carries a mutation in the EDMD/CMT ﬁbroblasts.
SUN2 speciﬁc antibodies showed a rim like staining pattern in DMD
and EDMD/CMT ﬁbroblasts comparable to wild type ﬁbroblasts
(data not shown). When we probed SUN2 expression at various
passages we found that at lower passages (p6, p4, respectively)
SUN2 expression is comparable to wild type ﬁbroblasts as analysed
by qRT-PCR, whereas at higher passages (p8, p16, respectively)
the expression level of SUN2 is remarkably decreased (Fig. 4a, b).
Immunoblot analysis of control and patient ﬁbroblasts with the
SUN2 speciﬁc mAb  K80-207-11 conﬁrmed the results obtained for
the mRNA at the protein level revealing a decrease in EDMD/CMT
cell lysates at higher passages (passage 6 vs passage 8 or 16, respec-
tively) (Fig. 4c, d).
The diminished SUN2 transcript levels in senescent patient cells
might be a consequence of the mutations in SUN1 and SUN2,
respectively, leading to a weakening of the interactions of the LINC
complex or through perturbed mechanotransduction and subse-
quent aberrant signalling pathways which in turn can affect the
levels of cellular and extracellular components.
The SUN2 proteome of EDMD/CMT ﬁbroblast cells differs from that
of control ﬁbroblast cellsIn independent work we  have generated a SUN2 proteome for
HaCaT cells and identiﬁed proteins belonging to several functional
classes (Vaylann and Noegel, unpublished). Here we  followed up
and extended this work and carried out pull down experiments
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Fig. 4. SUN2 transcript and protein levels in control and patient ﬁbroblasts at different passages. (a) Evaluation of Sun2 mRNA by qRT-PCR. The SUN2 mRNA levels in control
ﬁbroblasts at passage 8 were set at 1.0, EDMD/CMT ﬁbroblasts at passage 4 (p4), DMD  ﬁbroblasts at passage 6 (p6). Relative amounts as compared to control ﬁbroblasts are
shown.  (b) SUN2 transcript levels at higher passages. Control ﬁbroblasts at passage 22 were taken for reference. EDMD/CMT ﬁbroblasts at passage 16 (p16), DMD  ﬁbroblasts
at  passage 8 (p8). (c, d) SUN2 protein levels as determined by immunoblot analysis of lysates from control and patient ﬁbroblasts at different passages as indicated. For
loading  control the blots were probed for -tubulin. mAb  K80-207-11 was used for SUN2 detection, mAb  WA3  for -tubulin detection.
Fig. 5. SUN2 proteome of control and EDMD/CMT ﬁbroblasts. (a) Coomassie Blue stained SDS polyacrylamide gel (12% acrylamide) showing proteins from pull down assays
using  total control and EDMD/CMT cell lysates and GST-SUN2Nt as bait. Controls; ctrl1, GST-SUN2Nt beads incubated with PBS, ctrl2 and ctrl3, GST beads incubated with cell
lysate  from control ﬁbroblasts (ctrl2) and EDMD/CMT cell lysate (ctrl3). Input ctrl and input EDMD/CMT show the proteins that were precipitated using GST-SUN2Nt coated
beads  from the corresponding lysates. Arrows point to the analysed gel areas. Black arrows, protein bands present in both samples; grey arrows, diminished in control or
patient cell lysate; red arrows, only found in control or patient cell lysate. (b) Graphical representation of Sun2 binding partners in control and EDMD/CMT ﬁbroblasts. The
experiment was carried out twice. Only proteins that were detected in both analyses are shown. (c) Pull down experiments using GST (control) and GST-SUN2NT bound to
Sepharose beads to precipitate LaminA/C and Tubulin from control (WT) and patient ﬁbroblast lysates (EDMD/CMT and DMD). The precipitated proteins were detected with
appropriate antibodies.
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Table 1
Proteins in control and EDMD/CMT ﬁbroblast lysates that are precipitated by GST-SUN2Nt. They belong to the following categories, gene regulation (A), RNA processing (B),
architectural complex (C) and signalling (D). Identiﬁer indicates the SwissProt accession number if not stated otherwise. Ctrl, control ﬁbroblast lysate, EDMD/CMT, lysate
from  patient ﬁbroblasts. +, presence; −, absence.
Identiﬁer Name Category Ctrl EMD/CMT
Q9NVE4 (UniProtKB) CCDC87 A + +
P68104 (UniProtKB) EF1A1 B − +
NP  991247.1 HNRNPH1 B + +
O00571 mRNA helicase 3X B + −
EEF2  HUMAN EEF2 B + −
P60842 (UniProtKB) eIF4A-1 B + +
Q8N9N8 EIF1AD B − +
Q9UHB6 LIMA1 C + −
Q8WZ42 titin C − +
O43707.2 -Actinin1 C + −
P12814.2 -Actinin4 C + −
P41351 Tubulin  C + +
P05219 Tubulin  C + +
Q9ULV4.1 Coronin1C C + −
P02545.1 laminA/C* C, D + +
P68032 Actin* C, D + −
P35579 Myosin9* C, D + −
O00159 Myosin1c* C, D + −
Q8WXH0 Nesprin2* C, D + −
P53618.3 Coatomer  D + −
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P22314 Ubiquitin-like modiﬁer-activating enzym
ith total lysates from control and EDMD/CMT ﬁbroblasts using the
-terminus of SUN2, GST-SUN2Nt, as bait (Fig. 5a). This approach
ight help to identify possible differences in protein interaction
artners of SUN2 in control and patient ﬁbroblasts. The analy-
is was done by separating the protein complexes by SDS-PAGE
ollowed by LC–MS (liquid chromatography–mass spectrometry).
he identiﬁed proteins have roles in gene regulatory events (A), in
NA-processing complexes (B), in architectural complexes (C) and
n signalling (D) (Table 1). Fig. 5b summarises the data and illus-
rates the distribution of the proteins in control cell lysates and
DMD/CMT cell lysates. Some proteins are present in both lysates
Fig. 5b, intersection). Only one protein of category A, the coiled coil
omain containing protein 87 (CCDC87) which has homology to
AP65 (microtubule associated protein 65) in its C-terminus, was
hared by the proteomes of both cells. Equal numbers of proteins
articipating in RNA-processing were detected in both lysates. In
ontrol cell lysates signiﬁcantly more proteins contributing to cell
rchitecture and signalling events were found as compared to the
DMD/CMT cell lysate.
Proteins missing from the SUN2 proteome of EDMD/CMT cells
ere mainly actin cytoskeleton related proteins such as actin,
yosin1C and myosin9. Notably, Nesprin-2 was only found in con-
rol cell lysates, LaminA/C was identiﬁed in both lysates (Table 1 and
ig. 5b). The Nesprin-2 peptide identiﬁed in control cells matches
o a sequence in the last spectrin repeat which is present in the
esprin-2 isoforms Nesprin-2 Giant, Nesprin-22  and Nesprin-
1. We  veriﬁed some interactions by repeating the pull down
nd probing the presence of tubulin and LaminA/C in the precipi-
ate with antibodies (Fig. 5c). In this experiment we also included
 lysate from cells of the DMD  patient. LaminA/C was pulled down
n nearly comparable amounts from all cell lysates, whereas for
ubulin the signal in the DMD  pull down was strongly reduced in
omparison to control (WT) and EDMD/CMT cell lysates. GST was
sed for control.
xpression of mutant SUN1 and SUN2 proteins in HaCaT cellsSince SUN proteins are crucial components of the LINC com-
lex we decided to probe the impact of the mutations found in
he patients on this complex. The corresponding mutations were
ntroduced into the respective cDNAs by site directed mutagenesisD + −
D − +
D − +
and the mutant proteins expressed in HaCaT cells. For the mutage-
nesis plasmids GFP-hSun1 and Sun2-V5-His (Lu et al., 2008) were
used. Following transfection the presence of nuclear envelope com-
ponents was probed by immunoﬂuorescence analysis. We  observed
no changes at this level of analysis with regard to abundance and
distribution of Nesprin-2, Emerin and LaminB1 (Fig. 6a, b). The low
transfection efﬁciency prevented us from carrying out biochemical
analysis which could give information on the stability of the LINC
complex.
The nucleus-centrosome distance is increased in EDMD/CMT and
DMD ﬁbroblasts
The centrosome plays a key role in cellular architecture by deter-
mining the position of several associated organelles including the
nucleus. Previous data indicated that nuclear envelope proteins
like the LINC complex components and Emerin are participating in
centrosome-nucleus juxtaposition and mediate shuttling of nuclear
and centrosomal proteins between these organelles (Schneider
et al., 2011; Salpingidou et al., 2007). Therefore we investigated
the localisation of the centrosome relative to the nucleus using
antibodies against pericentrin (Fig. 7a, b). In control cells all cen-
trosomes were in close proximity of the nucleus (1.3 m mean
distance). Normal shaped as well as misshapen nuclei from patient
cells exhibited a slightly increased centrosome-nucleus distance
(Fig. 7b). The mean distance measured for DMD  cells was 3.25 m
and for EDMD/CMT ﬁbroblasts it had increased to 4 m (Fig. 7c).
The centrosome number per cell was not affected. In control as
well as in patient cells the centrosome nucleus number correlated
irrespective of the nuclear shape.
Cell adhesion is altered in patient ﬁbroblasts
Cell adhesion contributes substantially to the maintenance of
tissue structure, the promotion of cell migration, and the trans-
duction of information about the microenvironment of the cell.
Vinculin is a plasma membrane-associated cytoskeletal protein
in focal adhesion sites that is involved in the linkage of integrin
adhesion molecules to the actin cytoskeleton (Ziegler et al., 2006).
When we  assessed cell adhesion by vinculin staining we found that
all cell lines attached to the substratum and adhesion increased
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rogressively as revealed by vinculin staining (Fig. 8a). Control cells
ad at every time point the largest area of spreading on the sub-
tratum. Notably, when settling of the cells was completed after
5 min, the spreading area of the patient cells was  approximately
wo fold lower than that of the control cells (Table 2). A statistic
able 2
nalysis of cell spreading in control and patient ﬁbroblasts. The vinculin stained
rea on the surface of coverslips of control and patient ﬁbroblasts 15, 30, 45, 60 and
5  min  after seeding is measured in m2.
15 min  30 min  45 min  60 min  75 min
ctrl 1277.5 2385.51 2389.04 3882.86 7165.07
EDMD/CMT 978.02 936.09 1453.69 3058.94 3193.63
DMD 989.18 1126.05 1800.52 2691.37 4012.26 GFP-SUN1 carrying the mutation Q93P were analysed for Nesprin-2, Emerin and
2-V5-His carrying the mutation T33A were analysed. SUN2-V5-His was  recognised
evaluation of the adhesion ability showed that 30% of the control
cells had attached to the coverslip after 15 min. Attachment to the
substratum was signiﬁcantly lower in EDMD/CMT and DMD  cells
at 30 and 45 min  in comparison to the control cells. After 60 min
control and DMD  cells had attached completely and after 75 min
EDMD/CMT cells had also completed attachment (Fig. 8b).
Cell migration is altered in the mutant ﬁbroblasts in an in vitro
wound healing assayEarlier studies have demonstrated that mutations in key NE pro-
teins can result in slower migration rates of ﬁbroblasts (Houben
et al., 2009; Lee et al., 2007; Lüke et al., 2008). To investigate
whether the mutations in the patient cells studied in this report
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lso show similar defects we performed wound healing assays on
onﬂuent monolayers of patient ﬁbroblasts. This assay allows to
est the behaviour of the cells after physical injury of a cell layer
nd also to evaluate the migration behaviour and speed of the cells
hen they close the wound. Control ﬁbroblasts quickly migrated
nto the wound exhibiting a cell velocity of 10.4 ± 3.07 m per hour.
utant ﬁbroblasts oriented towards the wound, however the time
equired for wound closure was signiﬁcantly increased and the cell
elocities measured were reduced (6.9 ± 1.88 m for EDMD/CMT
nd 6.0 ± 0.81 m for DMD) (Fig. 9).enescence is increased in patient ﬁbroblasts
An increased senescence has been reported for cells harbour-
ng defects in components of the nuclear envelope (Le Dour et al.,nued ).
2011). When we  stained for the senescence marker -galactosidase
we  found that in control ﬁbroblasts of comparable passage num-
bers less than 1% of the cells were positive. In contrast, EDMD/CMT
cells revealed a positive staining in 11% of the cells, and in DMD
ﬁbroblasts this number increased to 14% (Fig. 10).
DMD ﬁbroblasts display hypersensitivity to heat shock treatment
It has been demonstrated that nuclei from laminopathy cells
are susceptible to heat stress (Vigouroux et al., 2001). To evaluate
the resistance of the nuclear envelope to damage induced by heat
stress, control and patient ﬁbroblasts were subjected to heat shock
treatment for 30 min  at 45 ◦C. Following the treatment, the cells
were immediately ﬁxed and stained for LaminB1 to assess nuclear
shape changes. In control cells LaminB1 distribution and nuclear
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Fig. 7. Nucleus-centrosome distance is altered in patient ﬁbroblasts. (a, b) Immunoﬂuorescence analysis of control (ctrl), EDMD/CMT and DMD  ﬁbroblasts using pericentrin
speciﬁc antibodies to localise the centrosome. Detection was with Alexa Fluor 488 conjugated secondary antibodies, DAPI was used for nuclear staining. A, normal shaped
nuclei,  B, irregular shaped nuclei. Size bar, 5 m.  (c) Statistical evaluation of the nucleus centrosome distance. Nucleus-centrosome mean distances were measured in m
w s each
o m,  an
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tith  Leica LAS AF Lite software. Fifty cells for control, EDMD/CMT, DMD ﬁbroblast
bserved distances between 0 and 1.30 m, for EDMD/CMT between 0 and 9.05 
ells),  6 (DMD) and 14 (EDMD/CMT).
hape were not dramatically altered upon heat stress whereas the
umber of deformed nuclei was increased (Fig. 11a, b). Fibroblasts
rom DMD patients displayed profound nuclear abnormalities after
reatment. Nuclear envelopes were deformed and disorganised into
olds and pleats and many had a rufﬂed appearance. Many nuclei
lso showed indentations (Fig. 11a, small arrowhead), tears in the
uclear envelope and extensive lobulations (Fig. 11a, asterisk). Fur-
her, heavily deformed nuclei appeared enlarged in both patient cell were examined. The error bars indicate standard deviations. For control cells we
d for DMD  they were between 0 and 8.67 m.  Passage numbers were 17 (control
lines suggesting an alteration in the nuclear protein network that
resulted in hypersensitivity to heat stress induced deformation. In
quantitative analysis we observed a higher number of deformed
nuclei in untreated patient cells as compared to control cells. This
number nearly doubled upon heat shock. A similar doubling was
also seen in heat treated control cells (Fig. 11b).
We  also determined whether heat shock affected the cen-
trosome positioning and stained for the centrosome marker
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Fig. 8. Cell surface adhesion in patient ﬁbroblasts. (a) Immunoﬂuorescence analysis of control and patient ﬁbroblasts 15, 30, 45, 60 and 75 min  after seeding. Staining was
f clear 
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tor  Vinculin. Alexa Fluor 488 conjugated secondary antibody was used, DAPI for nu
nd  patient ﬁbroblasts 15, 30, 45, 60 and 75 min  after seeding. At 90 min  after seed
ericentrin. We  found that the nucleosome–centrosome dis-
ance was slightly but not signiﬁcantly increased in control and
DMD/CMT ﬁbroblasts. In DMD  ﬁbroblasts the centrosome dis-
ance increased after heat shock. The difference was statistically
igniﬁcant (Fig. 11c).
iscussionHere we characterised dermal ﬁbroblasts from patients suf-
ering from DMD  and EDMD/CMT. In case of patient G-11235
he disease causing mutation was located in the dystrophinstaining. Scale bar, 76.4 m (shown in every panel). (b) Adhesion ability of control
achment was completed. The error bars indicate standard deviations.
gene, the mutation in patient G-11847 is not known. In addition
to the disease causing mutations the patients carry heterozy-
gous mutations in Nesprin-1 and in SUN1 (patient G-11235)
and SUN2 (G-11847) which are located in the N-termini of
the proteins. These mutations are normally not disease rel-
evant, however, in combination with further mutations they
may  enhance the phenotype. Nesprin-1 has been characterised
quite well. In particular, binding to Emerin and to LaminA/C
have been described. Furthermore, it can homodimerise through
its spectrin repeats 3 and 5 to form an antiparallel homod-
imer (Mislow et al., 2002b).  Whether these repeats also interact
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Fig. 9. In vitro wound healing is altered in patient ﬁbroblasts. (a) A cell migration assay was carried out to measure the wound healing capacity of patient ﬁbroblasts. Conﬂuent
monolayers of control, EDMD/CMT and DMD  ﬁbroblasts were scratched and wound closure was monitored by bright ﬁeld microscopy over 20 h. Representative images of
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Each  cell type at 0 h and 20 h are shown. (b) Graphical representation of the rate of m
eviations.
ith the related spectrin repeats of Nesprin-2 to form a
eterodimer cannot be excluded as recent work showed that
esprins can interact with each other and form a network sur-
ounding the nucleus (Taranum et al., 2012). In addition, through
ts C-terminal KASH domain Nesprin-1 is a component of the LINC
omplex (Padmakumar et al., 2005). The mutations in the N-termini
f SUN1 and SUN2, respectively, may  contribute to the observed
henotypes as they may  be able to interact with Nesprin-1 isoforms
n analogy to the observed interaction with Nesprin-2 isoforms.
hey also have the potential to bind to LaminA/C (Haque et al., 2010)
see discussion below).
Our analysis of the patient ﬁbroblast lines showed abnormal-
ties in the nuclear structure with concomitant mislocalisation of
esprins, Emerin, LaminA/C and LaminB1 at the NE, and alterations
n adhesion, migration and further physiological properties such as
ig. 10. Statistical evaluation of expression of -galactosidase as senescence
arker. Control and patient ﬁbroblasts were assayed for -galactosidase expres-
ion. The experiment was done in duplicate, 200 cells were counted each. The error
ars  indicate standard deviations. Control ﬁbroblasts were taken at passage 22,
DMD/CMT ﬁbroblasts at passage 16, and DMD  ﬁbroblasts at passage 8.ion. Each experiment was  repeated at least thrice. The error bars indicate standard
senescence and stress sensitivity which are in general characteristic
for ﬁbroblasts from laminopathies.
In general, nuclear defects have not been studied for DMD  cells
because Dystrophin is a protein of the sarcolemma. Lack of the pro-
tein affects the mechanical integrity of myoﬁbres and leaves them
vulnerable to mechanical stress. Furthermore, aberrant activation
of various signalling processes and increased apoptosis has been
observed (Le Dour et al., 2011; Kumar and Boriek, 2003). The mech-
anisms are however not clear. If we  consider the possibility that
there is a continuous link between the nucleoplasm, the NE, the
cytoskeleton and the plasma membrane, then Dystrophin at the
sarcolemma can be integrated into this scenario. It is then also not
surprising that the defects observed in DMD and laminopathies can
overlap and resemble each other. At the cellular level we did how-
ever not note obvious nuclear defects in DMD  myoblasts. The NE
related changes we  observed in the patient ﬁbroblasts may  there-
fore be a consequence of the additional mutations in the Nesprin-1
gene.
Interestingly, Nesprin-1 and Nesprin-2 are expressed in control
and mutant ﬁbroblasts and we observed alterations for both. Both
proteins have a similar overall structure and have similar or iden-
tical binding partners (Simpson and Roberts, 2008). Whether the
changes in Nesprin-1 and Nesprin-2 are due to a possible inter-
action between them or through alterations in the state of their
common binding partners Emerin and LaminA/C is not clear. In
case of the DMD  patient cells we found a reduction in Nesprin-
2 Giant at the NE in dysmorphic nuclei by immunoﬂuorescence
analysis although overall protein levels were not altered. Loss of
Nesprin-2 has been shown to cause severe nuclear morphology
defects in LMNA S143F progeria cells (Kandert et al., 2007) and
Nesprin-2 knockout mice show an increase in nuclear volume (Lüke
et al., 2008) suggesting that loss of Nesprin-2 Giant from the NE
results in nuclear morphology defects. The observed mislocalisa-
tion of Nesprin-2 may therefore be a factor that contributes to the
severity of the condition.
Increased fragility of the nucleus to heat shock has been reported
in patients with Dunnigan type familial partial lipodystrophy
(FPLD) as a functional consequence of an altered nuclear lamina
structure (Le Dour et al., 2011). Similar analyses with our patient
cells revealed that nuclei from both probands were hypersensitive
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Fig. 11. Heat shock induces severe nuclear shape alterations in DMD  and EDMD/CMT ﬁbroblasts. (a) Control and patient ﬁbroblasts were subjected to heat shock treatment
at  45 ◦C for 30 min  and ﬁxed immediately in ice cold methanol and immunolabelled for LaminB1. Untreated cells (left column) and heat stressed nuclei (middle and right
columns) as indicated on top are shown. Arrows and arrowheads point to alterations. Bar, 10 m.  (b) The number of deformed nuclei prior to and after heat shock was
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petermined. Cells were ﬁxed and stained for Emerin or with DAPI to reveal the nucle
tained for Emerin and Pericentrin as centrosomal marker. The experiment was ca
ells  were analysed per strain.
o heat stress. Patient nuclei showed extensive changes with the
ppearance of blebs, pleats, folds, and indentations in the nuclei
pon hyperthermic shock. Furthermore, enlargement of nuclei
pon heat shock was observed in both patient samples. A subset
f nuclei had a rufﬂed appearance and was extensively lobulated
ndicating diminished resistance to stress.
There is evidence that alterations in nuclear morphology cor-
elate with chromatin rearrangement possibly involved in the
ontrol of gene expression (D’Angelo and Hetzer, 2006). These
hanges include altered sub-nuclear targeting of transcription fac-
ors and/or nuclear domains. Principal components of chromatin
emodelling complexes include actin and actin regulatory proteins.
etween nuclear actin, LaminA/C and Emerin a molecular link has
een suggested (Clements et al., 2000; Fairley et al., 1999; Vaughan
t al., 2001). Previously reported and further elucidated in the
tudy by Haque et al. (2010),  is a direct interaction of LaminA/C
nd the N-termini of SUN1 and SUN2. Noteworthy, both patients
arry additional mutations in the N-termini of SUN1 (DMD) and
UN2 (EDMD/CMT), respectively. Loss or mutations that inhibit the
nteraction between one of those proteins could result in an altered
elationship between the NE and chromatin. This can be extended
o any protein that is a member of the LINC complex. Interestingly,
utative interaction partners of SUN2 differ signiﬁcantly as far as
rchitectural proteins are concerned in EDMD/CMT cell lysates in
omparison to control cell lysates. Actin and actin related proteins
ike -actinin, myosin and Nesprin-2 were only detected in control
ysates. Since LaminA/C was still present in EDMD/CMT cell lysates,
t is conceivable that the LaminA/C-SUN2 interaction is maintained
n EDMD/CMT cells, and the interruption might be therefore up-
r downstream of the LaminA/C-SUN2 connection. In any case, the
bsence of the actin complex in the patient cell lysate points to an
ltered cytoskeletal interaction.
Spectrin repeat proteins are known to associate with F-actin not
nly through their actin binding domains but also through binding
ites along the molecule (Djinovic-Carugo et al., 2002). In a hypo-
hetical scenario, mutated Nesprin-1 in EDMD/CMT cells might
eaken the actin complex interaction and, by doing so, contribute
o the disease phenotype. It is therefore conceivable that altered
xpression of LINC complex proteins and/or associated proteins
hich interact with a nuclear actin scaffold may  affect gene expres-
ion in repair and/or maintenance of muscle ﬁbres in laminopathy
atients. Further experiments assessing the interactions betweenpe. (c) Analysis of the nucleus centrosome distance after heat shock. The cells were
ut at passage number 14 (control cells), 16 (DMD), 13 (EDMD/CMT). One hundred
LINC complex proteins and actin complex proteins will shed light
on these questions.
The mutation in the dystrophin gene found in the DMD  patient
converts glutamic acid encoded by GAA/GAG into a premature ter-
mination codon resulting in a truncated protein which is lacking
a signiﬁcant part of its rod domain onto which many interactions
have been mapped. This loss of protein function might disconnect
the extra-cellular matrix from the cytoskeleton as these binding
sites are lost. Additionally, the mutation found in Nesprin-12  in
the DMD  patient and in Nesprin-11 in the EDMD/CMT patient
together with the SUN mutations being without consequences in
healthy individuals when occurring separately, might contribute
to weakened LINC complex protein interactions and thus perturb
signaling.
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